Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR.
Although microbial (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP) can activate primate Vgamma2Vdelta2 T cells, molecular mechanisms by which HMBPP interacts with Vgamma2Vdelta2 T cells remain poorly characterized. Here, we developed soluble, tetrameric Vgamma2Vdelta2 TCR of rhesus macaques to define HMBPP/APC interaction with Vgamma2Vdelta2 TCR. While exogenous HMBPP was associated with APC membrane in an appreciable affinity, the membrane-associated HMBPP readily bound to the Vgamma2Vdelta2 TCR tetramer. The Vgamma2Vdelta2 TCR tetramer was shown to bind stably to HMBPP presented on membrane by various APC cell lines from humans and nonhuman primates but not those from mouse, rat, or pig. The Vgamma2Vdelta2 TCR tetramer also bound to the membrane-associated HMBPP on primary monocytes, B cells and T cells. Consistently, endogenous phosphoantigen produced in Mycobacterium-infected dendritic cells was transported and presented on membrane, and bound stably to the Vgamma2Vdelta2 TCR tetramer. The capability of APC to present HMBPP for recognition by Vgamma2Vdelta2 TCR was diminished after protease treatment of APC. Thus, our studies elucidated an affinity HMBPP-APC association conferring stable binding to the Vgamma2Vdelta2 TCR tetramer and the protease-sensitive nature of phosphoantigen presentation. The findings defined APC presentation of phosphoantigen HMBPP to Vgamma2Vdelta2 TCR.
Wei
Huiyong
H
Department of Microbiology and Immunology, Center for Primate Biomedical Research, University of Illinois College of Medicine Chicago, Chicago, Illinois 60612, USA.
Huang
Dan
D
Lai
Xiaomin
X
Chen
Meiling
M
Zhong
Weihua
W
Wang
Richard
R
Chen
Zheng W
ZW
D000595:Amino Acid Sequence; D000818:Animals; D017951:Antigen Presentation / Q000235:genetics / Q000276:immunology*; D000938:Antigen-Presenting Cells / Q000276:immunology* / Q000378:metabolism*; D000942:Antigens, Bacterial / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism*; D002460:Cell Line; D045744:Cell Line, Tumor; D003713:Dendritic Cells / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D019281:Dimerization; D006801:Humans; D008253:Macaca mulatta; D051379:Mice; D008969:Molecular Sequence Data; D010755:Organophosphates / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D010750:Phosphoproteins / Q000276:immunology / Q000378:metabolism*; D011485:Protein Binding / Q000276:immunology; D051381:Rats; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D013552:Swine; D020298:U937 Cells
C467061:4-hydroxy-3-methyl-2-butenyl diphosphate; D000942:Antigens, Bacterial; D010755:Organophosphates; D010750:Phosphoproteins; D016692:Receptors, Antigen, T-Cell, gamma-delta; D011993:Recombinant Fusion Proteins
Immunol Rev. 2007 Feb;215:123-35
17291284
Cytometry. 1999 Dec 15;38(6):280-5
10589043
Cancer Res. 2007 Aug 1;67(15):7450-7
17671215
Infect Immun. 1998 Mar;66(3):1190-9
9488413
J Immunol. 1995 Feb 1;154(3):998-1006
7529807
Cell Microbiol. 2003 Jul;5(7):445-53
12814435
J Immunol. 2000 Dec 15;165(12):7133-9
11120844
J Virol. 2001 May;75(10):4713-20
11312343
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4560-5
15070757
J Biol Chem. 1999 Nov 5;274(45):32079-84
10542241
Tuber Lung Dis. 1999;79(5):279-85
10707256
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11408-12
7972074
Microbes Infect. 2005 Mar;7(3):518-28
15777667
Eur J Immunol. 2004 Aug;34(8):2248-56
15259022
J Exp Med. 1990 Apr 1;171(4):1171-88
2182762
J Immunol. 1991 Jan 1;146(1):35-9
1824593
Biotechnology (N Y). 1993 Oct;11(10):1138-43
7764094
J Biol Chem. 1996 Aug 16;271(33):20156-62
8702739
Microbes Infect. 2005 Mar;7(3):503-9
15823511
J Immunol. 2001 Jul 1;167(1):36-41
11418629
J Immunol. 2007 Dec 15;179(12):8287-96
18056373
J Immunol. 2001 Apr 1;166(7):4525-33
11254709
J Immunol. 2005 Oct 15;175(8):5481-8
16210656
J Biol Chem. 1993 Jul 25;268(21):15455-60
8340374
J Immunol. 2003 Apr 1;170(7):3696-706
12646635
Annu Rev Immunol. 2005;23:515-48
15771580
Immunol Rev. 2007 Feb;215:46-58
17291278
J Exp Med. 2003 Jan 20;197(2):163-8
12538656
Hum Immunol. 1997 Dec;58(2):70-82
9475336
Protein Sci. 1999 Apr;8(4):921-9
10211839
Science. 1996 Oct 4;274(5284):94-6
8810254
Scand J Immunol. 1999 Dec;50(6):642-50
10607313
Infect Immun. 2008 Jan;76(1):426-36
17923514
Trends Immunol. 2003 Apr;24(4):213-9
12697454
FEBS Lett. 2001 Dec 7;509(2):317-22
11741609
Nat Biotechnol. 2004 Nov;22(11):1429-34
15502816
Infect Immun. 1996 Mar;64(3):913-8
8641800
J Infect Dis. 1999 Sep;180(3):858-61
10438380
J Urol. 2005 May;173(5):1552-6
15821484
FEBS Lett. 2003 Jun 5;544(1-3):4-10
12782281
Immunol Rev. 2007 Feb;215:77-88
17291280
Blood. 2008 Apr 15;111(8):4220-32
18039956
Curr Biol. 1993 Oct 1;3(10):658-67
15335856
J Immunol. 2004 Apr 1;172(7):4167-75
15034029
Nature. 2001 Jun 14;411(6839):820-4
11459064
Science. 1990 Nov 30;250(4985):1269-73
1978758
Science. 2002 Mar 22;295(5563):2255-8
11910108